These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25927861)

  • 1. Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.
    Caballero Jde D; del Campo R; Tato M; Gómez G de la Pedrosa E; Cobo M; López-Causapé C; Gómez-Mampaso E; Oliver A; Cantón R;
    BMC Microbiol; 2014 Dec; 14():335. PubMed ID: 25927861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.
    Zhou J; Garber E; Desai M; Saiman L
    J Clin Microbiol; 2006 Apr; 44(4):1547-9. PubMed ID: 16597890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.
    Shelly DB; Spilker T; Gracely EJ; Coenye T; Vandamme P; LiPuma JJ
    J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is prolonged incubation required for optimal recovery of Burkholderia cepacia complex in sputum from cystic fibrosis patients? Data versus dogma.
    Naqvi S; Varadhan H; Givney R
    Pathology; 2020 Apr; 52(3):366-369. PubMed ID: 32113671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.
    Shreve MR; Butler S; Kaplowitz HJ; Rabin HR; Stokes D; Light M; Regelmann WE
    J Clin Microbiol; 1999 Mar; 37(3):753-7. PubMed ID: 9986845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.
    McMenamin JD; Zaccone TM; Coenye T; Vandamme P; LiPuma JJ
    Chest; 2000 Jun; 117(6):1661-5. PubMed ID: 10858399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
    Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis.
    Balke B; Schmoldt S; Häussler S; Suerbaum S; Heesemann J; Hogardt M
    J Cyst Fibros; 2008 Jan; 7(1):7-14. PubMed ID: 17658302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cough plates for microbiological surveillance in cystic fibrosis.
    Chavasse RJ; Cordle R; Petkar H
    Arch Dis Child; 2007 Mar; 92(3):279. PubMed ID: 17337701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.
    Kidd TJ; Bell SC; Coulter C
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):434-7. PubMed ID: 12884074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.
    Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D
    J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.
    Whitby PW; Dick HL; Campbell PW; Tullis DE; Matlow A; Stull TL
    J Clin Microbiol; 1998 Jun; 36(6):1642-5. PubMed ID: 9620393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.
    Jones AM; Webb AK
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):66-72. PubMed ID: 12906328
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and identification of Burkholderia cepacia by participants in an external Quality Assurance Program (QAP) between 1994 and 1999.
    Taylor PC; McLaws ML; De Borde M; Pritchard R
    Pathology; 2004 Aug; 36(4):352-7. PubMed ID: 15370136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.
    Tablan OC; Carson LA; Cusick LB; Bland LA; Martone WJ; Jarvis WR
    J Clin Microbiol; 1987 Mar; 25(3):485-7. PubMed ID: 3571451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part II: Recommendations for microbiological diagnosis in cystic fibrosis.
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):898-901. PubMed ID: 23272549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.